Understanding the Potential Drivers for Respiratory Syncytial Virus Rebound During the Coronavirus Disease 2019 Pandemic

Nonpharmaceutical interventions (NPIs) were widely introduced to combat the coronavirus disease 2019 (COVID-19) pandemic. These interventions also likely led to substantially reduced activity of respiratory syncytial virus (RSV). From late 2020, some countries observed out-of-season RSV epidemics. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, You, Wang, Xin, Cong, Bingbing, Deng, Shuyu, Feikin, Daniel R, Nair, Harish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807230/
https://www.ncbi.nlm.nih.gov/pubmed/35030633
http://dx.doi.org/10.1093/infdis/jiab606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807230/
https://www.ncbi.nlm.nih.gov/pubmed/35030633
http://dx.doi.org/10.1093/infdis/jiab606

Ejemplares similares